Propofol versus thiopental sodium for the treatment of refractory status epilepticus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Propofol Versus Thiopental Sodium for the Treatment of Refractory Status Epilepticus." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435816/all/Propofol_versus_thiopental_sodium_for_the_treatment_of_refractory_status_epilepticus.
Propofol versus thiopental sodium for the treatment of refractory status epilepticus. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/all/Propofol_versus_thiopental_sodium_for_the_treatment_of_refractory_status_epilepticus. Accessed February 10, 2025.
Propofol versus thiopental sodium for the treatment of refractory status epilepticus. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/all/Propofol_versus_thiopental_sodium_for_the_treatment_of_refractory_status_epilepticus
Propofol Versus Thiopental Sodium for the Treatment of Refractory Status Epilepticus [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/all/Propofol_versus_thiopental_sodium_for_the_treatment_of_refractory_status_epilepticus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Propofol versus thiopental sodium for the treatment of refractory status epilepticus
ID - 435816
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/all/Propofol_versus_thiopental_sodium_for_the_treatment_of_refractory_status_epilepticus
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -